Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1990 1
1992 1
1994 3
1995 2
1996 1
1997 2
1999 2
2000 5
2001 3
2002 7
2003 4
2004 7
2005 4
2006 1
2007 3
2008 6
2009 4
2010 5
2011 11
2012 13
2013 10
2014 7
2015 9
2016 10
2017 15
2018 14
2019 10
2020 10
2021 9
2022 17
2023 15
2024 13
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Immunology of bile acids regulated receptors.
Fiorucci S, Marchianò S, Urbani G, Di Giorgio C, Distrutti E, Zampella A, Biagioli M. Fiorucci S, et al. Among authors: di giorgio c. Prog Lipid Res. 2024 Jul;95:101291. doi: 10.1016/j.plipres.2024.101291. Epub 2024 Aug 8. Prog Lipid Res. 2024. PMID: 39122016 Review.
New potent EV-A71 antivirals targeting capsid.
Roux H, Touret F, Coluccia A, Khoumeri O, Di Giorgio C, Majdi C, Sciò P, Silvestri R, Vanelle P, Roche M. Roux H, et al. Among authors: di giorgio c. Eur J Med Chem. 2024 Oct 5;276:116658. doi: 10.1016/j.ejmech.2024.116658. Epub 2024 Jul 7. Eur J Med Chem. 2024. PMID: 39088999
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury.
Biagioli M, Marchianò S, di Giorgio C, Roselli R, Bordoni M, Bellini R, Fiorillo B, Sepe V, Catalanotti B, Cassiano C, Monti MC, Distrutti E, Zampella A, Fiorucci S. Biagioli M, et al. Among authors: di giorgio c. Hepatology. 2023 Jul 1;78(1):26-44. doi: 10.1002/hep.32787. Epub 2022 Oct 12. Hepatology. 2023. PMID: 36107019
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease.
Biagioli M, Marchianò S, Di Giorgio C, Bordoni M, Urbani G, Bellini R, Massa C, Sami Ullah Khan R, Roselli R, Chiara Monti M, Morretta E, Giordano A, Vellecco V, Bucci M, Jilani Iqbal A, Saviano A, Ab Mansour A, Ricci P, Distrutti E, Zampella A, Cieri E, Cirino G, Fiorucci S. Biagioli M, et al. Among authors: di giorgio c. Biochem Pharmacol. 2023 Dec;218:115900. doi: 10.1016/j.bcp.2023.115900. Epub 2023 Nov 3. Biochem Pharmacol. 2023. PMID: 37926268 Free article.
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism.
Biagioli M, Di Giorgio C, Massa C, Marchianò S, Bellini R, Bordoni M, Urbani G, Roselli R, Lachi G, Morretta E, Piaz FD, Charlier B, Fiorillo B, Catalanotti B, Cari L, Nocentini G, Ricci P, Distrutti E, Festa C, Sepe V, Zampella A, Monti MC, Fiorucci S. Biagioli M, et al. Among authors: di giorgio c. Biomed Pharmacother. 2024 Dec;181:117731. doi: 10.1016/j.biopha.2024.117731. Epub 2024 Dec 9. Biomed Pharmacother. 2024. PMID: 39657506 Free article.
Modeling Inflammatory Bowel Disease by Intestinal Organoids.
Di Giorgio C, Roselli R, Biagioli M, Bordoni M, Ricci P, Zampella A, Distrutti E, Donini A, Fiorucci S. Di Giorgio C, et al. Recent Adv Inflamm Allergy Drug Discov. 2023;17(1):39-53. doi: 10.2174/2772270817666221121143853. Recent Adv Inflamm Allergy Drug Discov. 2023. PMID: 36411558 Review.
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery.
Labadie JG, Ibrahim SA, Worley B, Kang BY, Rakita U, Rigali S, Arndt KA, Bernstein E, Brauer JA, Chandra S, Didwania A, DiGiorgio C, Donelan M, Dover JS, Galadari H, Geronemus RG, Goldman MP, Haedersdal M, Hruza G, Ibrahimi OA, Kauvar A, Kelly KM, Krakowski AC, Miest R, Orringer JS, Ozog DM, Ross EV, Shumaker PR, Sobanko JF, Suozzi K, Taylor MB, Teng JMC, Uebelhoer NS, Waibel J, Wanner M, Ratchev I, Christensen RE, Poon E, Miller CH, Alam M. Labadie JG, et al. JAMA Dermatol. 2022 Oct 1;158(10):1193-1201. doi: 10.1001/jamadermatol.2022.3234. JAMA Dermatol. 2022. PMID: 35976634 Free article.
214 results